Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Richard Ziehr, M.D.

Concepts (125)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial3202123840.800 Why?
Pulmonary Gas Exchange120203880.740 Why?
Coronavirus Infections3202032230.670 Why?
Pneumonia, Viral3202033440.670 Why?
Respiratory Mechanics120206660.620 Why?
Prostatic Neoplasms152015104390.610 Why?
Pandemics3202058590.500 Why?
Respiratory Insufficiency1202011000.480 Why?
Physical Phenomena12010490.430 Why?
African Americans5201451440.330 Why?
Ribosomes120105540.320 Why?
Income1201417950.300 Why?
Androgen Antagonists1201412700.290 Why?
Antineoplastic Agents, Hormonal1201415420.290 Why?
Molecular Chaperones120107710.290 Why?
SEER Program7201515700.230 Why?
Healthcare Disparities5201429720.230 Why?
Prone Position120201780.200 Why?
Coronary Disease1201462210.190 Why?
Renal Replacement Therapy120202390.180 Why?
Patient Positioning120203090.170 Why?
Reference Standards120208910.170 Why?
Prostatectomy3201518110.170 Why?
Administration, Inhalation1202011190.170 Why?
Vasoconstrictor Agents120206170.160 Why?
Brachytherapy2201512920.160 Why?
Lactic Acid1202111190.160 Why?
Positive-Pressure Respiration120206110.150 Why?
Fluid Therapy120206010.150 Why?
Vasodilator Agents1202010040.150 Why?
Renal Insufficiency120207860.140 Why?
Goserelin120141320.140 Why?
Vascular Endothelial Growth Factor Receptor-2120165790.130 Why?
Anilides120164160.130 Why?
Leuprolide120143150.120 Why?
Intubation, Intratracheal1202012500.120 Why?
Insurance Coverage2201417950.120 Why?
Health Status Disparities2201417140.120 Why?
Proto-Oncogene Proteins c-met120166030.120 Why?
Organs at Risk120143250.120 Why?
Intensive Care Units2202132630.110 Why?
Prostate-Specific Antigen3201522110.110 Why?
Diabetes Mellitus2202049580.110 Why?
Hydroxylamine12010170.110 Why?
Puromycin12010760.110 Why?
Sodium Hydroxide12010480.110 Why?
Extracorporeal Membrane Oxygenation1202011390.100 Why?
Fluorescence Polarization120101320.100 Why?
Ultracentrifugation120102100.100 Why?
Edetic Acid120102980.100 Why?
Ribonuclease, Pancreatic120101560.100 Why?
Lung Diseases1202019100.100 Why?
Metformin120157400.100 Why?
Rectum120149050.090 Why?
Sepsis1202123090.090 Why?
Aged1620211622710.090 Why?
Neoplasms, Second Primary120159620.090 Why?
Middle Aged1620212164680.090 Why?
Hospital Mortality1202150650.080 Why?
Prostate1201514320.080 Why?
Adenocarcinoma2201564500.080 Why?
Salvage Therapy1201413110.080 Why?
Aged, 80 and over62020593310.080 Why?
Geriatric Assessment1201412540.080 Why?
Protein Folding120108830.080 Why?
Male1920213524650.080 Why?
Humans2220216866630.070 Why?
Comorbidity12020106480.070 Why?
Cohort Studies22020387320.070 Why?
Retrospective Studies62021673200.070 Why?
Pyridines1201628430.070 Why?
Risk Factors92021692780.070 Why?
United States92021655790.060 Why?
Body Mass Index12021123230.060 Why?
Severity of Illness Index12021162270.060 Why?
Escherichia coli Proteins1201011340.060 Why?
Smoking1202090290.060 Why?
Protein Biosynthesis1201022140.060 Why?
Insurance, Health1201424790.060 Why?
Hypertension1202079410.050 Why?
Critical Illness2202123510.050 Why?
Logistic Models12014138070.050 Why?
Obesity12021117000.050 Why?
Vascular Endothelial Growth Factor D12016720.040 Why?
Socioeconomic Factors3201579330.040 Why?
Risk Assessment22015237390.040 Why?
Young Adult22020560520.040 Why?
Neoplasm Recurrence, Local1201486100.040 Why?
Adult620202114000.040 Why?
Massachusetts2202189200.040 Why?
Europe1202132770.030 Why?
Androgen Receptor Antagonists120151180.030 Why?
Patient Protection and Affordable Care Act2201411400.030 Why?
Minority Health12014800.030 Why?
Diagnosis-Related Groups120154580.030 Why?
Survival Rate22021136060.030 Why?
Marital Status120154350.030 Why?
Age Factors32015192950.030 Why?
Incidence32015204960.030 Why?
Risk2201599150.030 Why?
Postoperative Complications12014150830.030 Why?
Female520213754590.030 Why?
Epidemiologic Methods1201514140.020 Why?
Biopsy, Needle1201517100.020 Why?
Age of Onset1201533730.020 Why?
Magnetic Resonance Imaging12015331860.020 Why?
Radiotherapy Dosage1201429910.020 Why?
Neoplasms12014195380.020 Why?
Disease-Free Survival1201671950.020 Why?
Kaplan-Meier Estimate1201669700.020 Why?
Neoplasm Metastasis1201653910.020 Why?
Feasibility Studies1201448070.020 Why?
Molecular Targeted Therapy1201628840.020 Why?
Population Surveillance1201426930.020 Why?
Mortality1201428220.010 Why?
Follow-Up Studies22015397370.010 Why?
Hospitalization1202193040.010 Why?
Prognosis12021289230.010 Why?
Survival Analysis12014107660.010 Why?
Neoplasm Staging12015112650.010 Why?
Protein Kinase Inhibitors1201652520.010 Why?
Databases, Factual1201578650.010 Why?
Predictive Value of Tests12015154070.010 Why?
Quality of Life12014106760.010 Why?
Treatment Outcome12014609910.010 Why?
Ziehr's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (125)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.